-
Bromocriptine, a dopamine receptor agonist initially approved in 1978 as Parlodel®, has been approved for the treating type 2 diabetes mellitus. The drug is marketed as a quick release formulation by VeroScience LLC as Cycloset™.
-
Group visits of diabetic patients have the power to foster lifestyle change, improve the control of diabetes and related cardiovascular risk factors, and lower health care costs.
-
Aspirin reduces the risk for myocardial infarction in men ages 45-79 and for stroke in women ages 55-79; however, its use must be balanced against the increased risk of serious bleeding events in each individual patient.
-
-
This brief pilot intervention trial grew out of data suggesting that symptoms of fibromyalgia are often worse during cold weather, and that the skin temperature associated directly with specific trigger points may be lower than in healthy subjects.
-
A randomized, double-blind study found that alpha-linolenic acid (an omega-3 fatty acid) supplementation provided few additional benefits for older adults participating in a 12-week resistance-training program.
-
In-depth laboratory analysis suggests that human semen (SE) contains a peptide that enhances HIV infectivity, but the green tea polyphenol epigallocatechin-3-gallate (EGCG) inhibits the increased infectivity associated with the peptide. This raises the possibility that topical intravaginal EGCG could be a useful adjunct in controlling the spread of HIV infection.
-
According to results of a gallup organization survey released during the American College of Obstetricians and Gynecologists (ACOG) 57th Annual Clinical meeting in Chicago, women are delaying important preventive care—in the form of pregnancy and annual check-ups—as a result of the economy.
-
Subgroups of U.S. adults who are minorities, poor, or undereducated with chronic cardiovascular risk factors such as hypertension, diabetes, and hypercholesterolemia have large disparities in treatment for these conditions compared with white, high school-educated adults when they are uninsured or underinsured.
-
Several large observational studies have suggested that vitamin E supplementation lowers the risk of coronary heart disease. However, the results of large randomized controlled trials failed to show a clear benefit of a-tocopherol supplementation on cardiovascular outcomes.